GEODE CAPITAL MANAGEMENT, LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 51 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$77,000
-43.4%
59,849
-6.8%
0.00%
Q3 2017$136,000
-26.9%
64,2280.0%0.00%
Q2 2017$186,000
-18.1%
64,228
-2.9%
0.00%
Q1 2017$227,000
+99.1%
66,120
+0.4%
0.00%
Q4 2016$114,000
-47.7%
65,862
+0.3%
0.00%
Q3 2016$218,00065,6900.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
GLG LLC 1,524,143$1,966,0000.14%
BVF INC/IL 734,976$948,0000.11%
Old West Investment Management, LLC 77,254$99,0000.06%
Telemetry Investments, L.L.C. 64,464$83,0000.03%
Baupost Group 2,226,839$2,873,0000.03%
NEA Management Company, LLC 370,900$478,0000.02%
IFG Advisory, LLC 49,000$63,0000.01%
Rock Springs Capital Management LP 165,300$213,0000.01%
Virtu Financial LLC 50,290$65,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 133,658$172,0000.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders